Actively Recruiting
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
Led by UMC Utrecht · Updated on 2025-12-31
1008
Participants Needed
1
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.
CONDITIONS
Official Title
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Couples starting IUI with Mild Ovarian HyperStimulation (MOH) intending to continue treatment for at least six months
- Diagnosed with unexplained (primary or secondary) infertility
- Hunault score less than 30%, or greater than 30% after at least 6 months of expectant management
- Female participants aged over 18 years with regular menstrual cycles
- Total mobile sperm count greater than 10 million
You will not qualify if you...
- Irregular menstrual cycles
- Male factor infertility
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UMC Utrecht
Utrecht, Netherlands
Actively Recruiting
Research Team
S
Simone Broer, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here